195 related articles for article (PubMed ID: 22828815)
1. Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease.
Stirnemann J; Letellier E; Aras N; Borne M; Brinquin L; Fain O
Diving Hyperb Med; 2012 Jun; 42(2):82-4. PubMed ID: 22828815
[TBL] [Abstract][Full Text] [Related]
2. The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease.
Tawfic QA; Faris AS; Kausalya R
J Pain Symptom Manage; 2014 Feb; 47(2):334-40. PubMed ID: 23856095
[TBL] [Abstract][Full Text] [Related]
3. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
4. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
5. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
6. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
7. Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
Mathias MD; McCavit TL
Pediatrics; 2015 Mar; 135(3):475-82. PubMed ID: 25667245
[TBL] [Abstract][Full Text] [Related]
8. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
9. Oral morphine protocol for sickle cell crisis pain.
Conti C; Tso E; Browne B
Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
[TBL] [Abstract][Full Text] [Related]
10. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
13. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
[TBL] [Abstract][Full Text] [Related]
14. Opioid management and dependency among adult patients with sickle cell disease.
Feliu MH; Wellington C; Crawford RD; Wood M; Edwards L; Byrd G; Edwards CL
Hemoglobin; 2011; 35(5-6):485-94. PubMed ID: 21910605
[TBL] [Abstract][Full Text] [Related]
15. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
[TBL] [Abstract][Full Text] [Related]
16. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
[TBL] [Abstract][Full Text] [Related]
17. [Sickle-cell anemia and pain].
de la Brière A
Soins; 2012; (767):14-7. PubMed ID: 22916389
[TBL] [Abstract][Full Text] [Related]
18. Treatment of the acute sickle cell vaso-occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine.
Campos J; Lobo C; Queiroz AM; do Nascimento EM; Lima CB; Cardoso G; Ballas SK
Eur J Haematol; 2014 Jul; 93(1):34-40. PubMed ID: 24571671
[TBL] [Abstract][Full Text] [Related]
19. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
Allen Liles E; Kirsch J; Gilchrist M; Adem M
Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
[TBL] [Abstract][Full Text] [Related]
20. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
